Cargando…

Association investigations between ACE1 and ACE2 polymorphisms and severity of COVID-19 disease

Due to the unique affinity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to the angiotensin-converting enzyme 2 (ACE2) receptor in patients, the foremost recent evidence indicated that ACE1 and ACE2 polymorphisms could affect the susceptibility of individuals to SARS-CoV-2 infe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Najafi, Mojtaba, Mahdavi, Mohammad Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579601/ https://www.ncbi.nlm.nih.gov/pubmed/36255490 http://dx.doi.org/10.1007/s00438-022-01953-8

Ejemplares similares

Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease
por: Sabater Molina, Maria, et al.
Publicado: (2022)

The Relation between ACE Gene Polymorphism and the Severity of COVID-19 Infection
por: El-Sayed Marei, Yara, et al.
Publicado: (2023)

Assessment of ACE1 variants and ACE1/ACE2 expression in COVID-19 patients
por: Akbari, Mohammadarian, et al.
Publicado: (2022)

Association of ACE1 I/D rs1799752 and ACE2 rs2285666 polymorphisms with the infection and severity of COVID‐19: A meta‐analysis
por: Aziz, Md. Abdul, et al.
Publicado: (2022)

The Role of ACE, ACE2, and AGTR2 Polymorphisms in COVID-19 Severity and the Presence of COVID-19-Related Retinopathy
por: Jevnikar, Kristina, et al.
Publicado: (2022)

ACE polymorphism and COVID-19 outcome
por: Delanghe, Joris R., et al.
Publicado: (2020)

ACE and ACE2 Gene Variants Are Associated With Severe Outcomes of COVID-19 in Men
por: Martínez-Gómez, Laura E., et al.
Publicado: (2022)

Investigating the ACE2 polymorphisms in COVID‐19 susceptibility: An in silico analysis
por: Pouladi, Nasser, et al.
Publicado: (2021)

The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy
por: Chen, Fei, et al.
Publicado: (2021)

ACE2, COVID19 and serum ACE as a possible biomarker to predict severity of disease
por: Skarstein Kolberg, Espen
Publicado: (2020)

ACE2 polymorphisms impact COVID-19 severity in obese patients
por: Jalaleddine, Nour, et al.
Publicado: (2022)

The association of ACE1, ACE2, TMPRSS2, IFITM3 and VDR polymorphisms with COVID-19 severity: A systematic review and meta-analysis
por: Dobrijevic, Zorana, et al.
Publicado: (2022)

Genotype variation of ACE and ACE2 genes affects the severity of COVID-19 patients
por: Faustine, Ingrid, et al.
Publicado: (2023)

The role of ACE1 I/D and ACE2 polymorphism in the outcome of Iranian COVID-19 patients: A case-control study
por: Faridzadeh, Arezoo, et al.
Publicado: (2022)

The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19
por: Bosso, Mira, et al.
Publicado: (2020)

ACE polymorphisms and COVID-19-related mortality in Europe
por: Bellone, Matteo, et al.
Publicado: (2020)

COVID-19 susceptibility: potential of ACE2 polymorphisms
por: Chaudhary, Mayank
Publicado: (2020)

ACE2 Elevation in Severe COVID-19
por: Reindl-Schwaighofer, Roman, et al.
Publicado: (2021)

ACE2 and COVID-19 Susceptibility and Severity
por: Zheng, Ming
Publicado: (2022)

ACE2 and Diabetes: ACE of ACEs?
por: Batlle, Daniel, et al.
Publicado: (2010)

ACE1 polymorphism and progression of SARS
por: Itoyama, Satoru, et al.
Publicado: (2004)

Associations of ACE Gene Insertion/Deletion Polymorphism, ACE Activity, and ACE mRNA Expression with Hypertension in a Chinese Population
por: He, Qingfang, et al.
Publicado: (2013)

Angiotensin-Converting Enzyme (ACE) level, but not ACE gene polymorphism, is associated with prognosis of COVID-19 infection: Implications for diabetes and hypertension
por: Elbasan, Onur, et al.
Publicado: (2023)

Variants in ACE2; potential influences on virus infection and COVID-19 severity
por: Bakhshandeh, Behnaz, et al.
Publicado: (2021)

Severity of coronavirus disease 19: Profile of inflammatory markers and ACE (rs4646994) and ACE2 (rs2285666) gene polymorphisms in Iraqi patients
por: Mahmood, Zainab S., et al.
Publicado: (2022)

ACE polymorphism and diabetic nephropathy
por: Wiwanitkit, V.
Publicado: (2010)

ACE polymorphism in asthmatic patients
por: Cortez, Margarida, et al.
Publicado: (2013)

The ACE rs1799752 Variant Is Associated with COVID-19 Severity but Is Independent of Serum ACE Activity in Hospitalized and Recovered Patients
por: Fricke-Galindo, Ingrid, et al.
Publicado: (2023)

Correction: Associations of ACE Gene Insertion/Deletion Polymorphism, ACE Activity, and ACE mRNA Expression with Hypertension in a Chinese Population
por: He, Qingfang, et al.
Publicado: (2016)

ACE2 polymorphisms as potential players in COVID-19 outcome
por: Khayat, André Salim, et al.
Publicado: (2020)

Impact of I/D polymorphism of angiotensin-converting enzyme 1 (ACE1) gene on the severity of COVID-19 patients
por: Verma, Sushma, et al.
Publicado: (2021)

ACE and ACE2: insights from Drosophila and implications for COVID-19
por: Herrera, Paul, et al.
Publicado: (2021)

Association between circulating levels of ACE2-Ang-(1–7)-MAS axis and ACE2 gene polymorphisms in hypertensive patients
por: Liu, Dan, et al.
Publicado: (2016)

Global distribution of ACE1 (rs4646994) and ACE2 (rs2285666) polymorphisms associated with COVID-19: A systematic review and meta-analysis
por: Keikha, Masoud, et al.
Publicado: (2022)

Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
por: Abd El-Aziz, Tarek Mohamed, et al.
Publicado: (2020)

ACE/ACE2 balance might be instrumental to explain the certain comorbidities leading to severe COVID-19 cases
por: Bank, Sarbashri, et al.
Publicado: (2021)

Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19
por: Şenkal, Naci, et al.
Publicado: (2020)

ACE/ACE2 Ratio: A Key Also in 2019 Coronavirus Disease (Covid-19)?
por: Pagliaro, Pasquale, et al.
Publicado: (2020)

COVID-19: Acing the Treatment
por: Hunter, Jez, et al.
Publicado: (2022)

ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19
por: Möhlendick, Birte, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ptdhbtn7gspi4bef0n9r9ner4e